Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Hereditary Paraganglioma-Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 12 | 12 |
|
Hereditary endocrine cancer panel. NGS panel of 22 genes. Genologica Medica Spain | 68 | 22 |
|
Hereditary kidney cancer panel. NGS panel of 26 genes. Genologica Medica Spain | 74 | 26 |
|
Hereditary Paraganglioma-Pheochromocytoma Genologica Medica Spain | 32 | 12 |
|
Asper Biogene Asper Biogene LLC Estonia | 48 | 25 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
GeneDx United States | 103 | 82 |
|
Common Cancer Management Panel GeneDx United States | 56 | 37 |
|
Comprehensive Common Cancer Panel GeneDx United States | 60 | 47 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Paragangliomas: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 5 | 5 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Hereditary Pheochromocytoma-Paraganglioma Syndrome , Panel Massive Sequencing (NGS) 11 Genes Reference Laboratory Genetics Spain | 9 | 11 |
|
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes Reference Laboratory Genetics Spain | 126 | 90 |
|
Hereditary Pheochromocytoma-Paraganglioma Syndrome, Deletions-Duplications (MLPA) SDHD Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 1, Sequencing SDHD/PGL1Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Comprehensive Hereditary Cancer Panel Baylor Genetics United States | 132 | 61 |
|
Hereditary Endocrine Cancer Panel Baylor Genetics United States | 51 | 15 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.